UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A review of avascular necrosis, of the hip and beyond

La revue de medecine interne, 2020-01, Vol.41 (1), p.27

2020

Volltextzugriff (PDF)

Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat

Clinical rheumatology, 2022-05, Vol.41 (5), p.1421-1429

2022

Volltextzugriff (PDF)

FRI0286 Rank-l is expressed by salivary gland epithelial cells in primary sjogren’s syndrome: a novel actor in ectopic lymphoid structure neogenesis

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.680

2018

Volltextzugriff (PDF)

FRI0249 IN MYOSITIS PATIENTS, SJÖGREN’S SYNDROME IS ASSOCIATED WITH INCLUSION BODY MYOSITIS AND WITH ANTI-CN1A ANTIBODIES INDEPENDENTLY OF THE MYOSITIS SUBTYPE

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.708-709

2020

Volltextzugriff (PDF)

SAT0454 In primary sjÖgren’s syndrome blood cd180-negative b cells are increased in patients with high systemic disease activity

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1086

2018

Volltextzugriff (PDF)

AB0410 Diagnosis of lung disease associated with rheumatoid arthritis, a prospective monocentric study

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1369

2018

Volltextzugriff (PDF)

SAT0470 Myositis, often suspected, is actually rare in primary sjÖgren’s syndrome: data from the french cohort assess

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.1093

2018

Volltextzugriff (PDF)

THU0248 Therapeutic Interest of anti-CD3 and Anti-Baff Monoclonal Antibodies in The Nod Model of Sjögren's Syndrome

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.277-278

2016

Volltextzugriff (PDF)

AB0441 IMPACT OF URICEMIA ON PSORIATIC ARTHRITIS, AND ON SAFETY AND CLINICAL RESPONSE TO UPADACITINIB AND ADALIMUMAB: POST-HOC ANALYSIS OF PHASE III STUDIES

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.1479-1480

2024

Volltextzugriff (PDF)

Unilateral mydriasis in Lyme neuroborreliosis

Revue neurologique, 2015-05, Vol.171 (5), p.451

2015

Volltextzugriff (PDF)

AB0121 STUDY OF SLAMF7 EXPRESSION IN PRIMARY GOUGEROT-SJÖGREN SYNDROME

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1191-1191

2022

Volltextzugriff (PDF)

POS0813 ALTERATION OF ILC HOMEOSTASIS MAINLY CONCERNS SALIVARY GLANDS IN PRIMARY SJÖGREN’S SYNDROME

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.701-702

2023

Volltextzugriff (PDF)

POS1393 LUPUS PREGNANCIES ARE CHARACTERIZED BY A DISTINCT INFLAMMATORY TRANSCRIPTOMIC SIGNATURE PARTLY DRIVEN BY SPECIFIC MIRNA

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.931-932

2024

Volltextzugriff (PDF)

POS0758 DOES EXPERIENCE IN SYSTEMIC LUPUS ERYTHEMATOSUS INFLUENCE THE PHYSICIAN GLOBAL ASSESSMENT SCORING? A CROSS-SECTIONAL STUDY ON TWO EUROPEAN COHORTS

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.632-632

2021

Volltextzugriff (PDF)

Ostéonécroses aseptiques, une revue générale des ostéonécroses de la hanche, et au-delà

La revue de medecine interne, 2020-01, Vol.41, p.27-36

2020

Volltextzugriff (PDF)

POS1065 IMPACT OF HYPERURICEMIA ON CLINICAL PHENOTYPE, COMORBIDITIES, AND RESPONSE TO SECUKINUMAB IN PSORIATIC ARTHRITIS: POST HOC ANALYSIS OF FUTURE AND MAXIMISE STUDIES

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.855-855

2022

Volltextzugriff (PDF)

Ostéonécroses aseptiques, une revue générale des ostéonécroses de la hanche, et au-delà

La revue de medecine interne, 2020-01, Vol.41 (1), p.27-36

2020

Volltextzugriff (PDF)

Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date

Drug design, development and therapy, 2019-01, Vol.13, p.1535-1543

2019

Volltextzugriff (PDF)

AB0332 IMMUNOSUPPRESSIVE AND IMMONOMODULATING AGENTS IN RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW OF CLINICAL TRIALS AND THEIR CURRENT DEVELOPMENT STAGE

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1464-1465

2020

Volltextzugriff (PDF)

Changer de mode d’action permet un meilleur maintien thérapeutique qu’un second anti-TNF après échec d’un anti-TNF en première ligne de traitement ciblé : données de vraie vie de 488 patients atteints de rhumatisme psoriasique

Revue du rhumatisme (Ed. française : 1993), 2022-12, Vol.89, p.A101-A101

2022

Volltextzugriff (PDF)

Type 1 interferons: A target for immune-mediated inflammatory diseases (IMIDs)

Joint, bone, spine : revue du rhumatisme, 2024-03, Vol.91 (2), p.105627, Article 105627

2024

Volltextzugriff (PDF)

POS0947 PSORIATIC ARTHRITIS WITH HYPERURICEMIA: MORE PERIPHERAL, DESTRUCTIVE AND CHALLENGING TO TREAT

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.736-737

2021

Volltextzugriff (PDF)

POS0533 REPURPOSING FIB-4 SCORE IN RHEUMATOID ARTHRITIS: DATA FROM THE ESPOIR COHORT

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.528-528

2022

Volltextzugriff (PDF)

OP0210 BRUTON’S TYROSINE KINASE (BTK) IS A NOVEL INDEPENDENT BIOMARKER OF LYMPHOMA IN PRIMARY SJÖGREN’S SYNDROME: DATA FROM 346 PATIENTS OF THE ASSESS COHORT

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.138-138

2023

Volltextzugriff (PDF)

Étude de l’expression de la molécule SLAMF7 au cours du syndrome de Gougerot-Sjögren primaire

Revue du rhumatisme (Ed. française : 1993), 2021-12, Vol.88, p.A129

2021

Volltextzugriff (PDF)

1 – 25 von 471

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(341)
Mit Volltextzugriff
(363)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A review of avascular necrosis, of the hip and beyond

Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat

FRI0286 Rank-l is expressed by salivary gland epithelial cells in primary sjogren’s syndrome: a novel actor in ectopic lymphoid structure neogenesis

FRI0249 IN MYOSITIS PATIENTS, SJÖGREN’S SYNDROME IS ASSOCIATED WITH INCLUSION BODY MYOSITIS AND WITH ANTI-CN1A ANTIBODIES INDEPENDENTLY OF THE MYOSITIS SUBTYPE

SAT0454 In primary sjÖgren’s syndrome blood cd180-negative b cells are increased in patients with high systemic disease activity

AB0410 Diagnosis of lung disease associated with rheumatoid arthritis, a prospective monocentric study

SAT0470 Myositis, often suspected, is actually rare in primary sjÖgren’s syndrome: data from the french cohort assess

THU0248 Therapeutic Interest of anti-CD3 and Anti-Baff Monoclonal Antibodies in The Nod Model of Sjögren's Syndrome

AB0441 IMPACT OF URICEMIA ON PSORIATIC ARTHRITIS, AND ON SAFETY AND CLINICAL RESPONSE TO UPADACITINIB AND ADALIMUMAB: POST-HOC ANALYSIS OF PHASE III STUDIES

Unilateral mydriasis in Lyme neuroborreliosis

AB0121 STUDY OF SLAMF7 EXPRESSION IN PRIMARY GOUGEROT-SJÖGREN SYNDROME

POS0813 ALTERATION OF ILC HOMEOSTASIS MAINLY CONCERNS SALIVARY GLANDS IN PRIMARY SJÖGREN’S SYNDROME

POS1393 LUPUS PREGNANCIES ARE CHARACTERIZED BY A DISTINCT INFLAMMATORY TRANSCRIPTOMIC SIGNATURE PARTLY DRIVEN BY SPECIFIC MIRNA

POS0758 DOES EXPERIENCE IN SYSTEMIC LUPUS ERYTHEMATOSUS INFLUENCE THE PHYSICIAN GLOBAL ASSESSMENT SCORING? A CROSS-SECTIONAL STUDY ON TWO EUROPEAN COHORTS

Ostéonécroses aseptiques, une revue générale des ostéonécroses de la hanche, et au-delà

POS1065 IMPACT OF HYPERURICEMIA ON CLINICAL PHENOTYPE, COMORBIDITIES, AND RESPONSE TO SECUKINUMAB IN PSORIATIC ARTHRITIS: POST HOC ANALYSIS OF FUTURE AND MAXIMISE STUDIES

Ostéonécroses aseptiques, une revue générale des ostéonécroses de la hanche, et au-delà

Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date

AB0332 IMMUNOSUPPRESSIVE AND IMMONOMODULATING AGENTS IN RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW OF CLINICAL TRIALS AND THEIR CURRENT DEVELOPMENT STAGE

Changer de mode d’action permet un meilleur maintien thérapeutique qu’un second anti-TNF après échec d’un anti-TNF en première ligne de traitement ciblé : données de vraie vie de 488 patients atteints de rhumatisme psoriasique

Type 1 interferons: A target for immune-mediated inflammatory diseases (IMIDs)

POS0947 PSORIATIC ARTHRITIS WITH HYPERURICEMIA: MORE PERIPHERAL, DESTRUCTIVE AND CHALLENGING TO TREAT

POS0533 REPURPOSING FIB-4 SCORE IN RHEUMATOID ARTHRITIS: DATA FROM THE ESPOIR COHORT

OP0210 BRUTON’S TYROSINE KINASE (BTK) IS A NOVEL INDEPENDENT BIOMARKER OF LYMPHOMA IN PRIMARY SJÖGREN’S SYNDROME: DATA FROM 346 PATIENTS OF THE ASSESS COHORT

Étude de l’expression de la molécule SLAMF7 au cours du syndrome de Gougerot-Sjögren primaire

Suchergebnisse filtern